Value of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) in prediction of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization

ZHU Zheng; ZHAO Xinming; ZHOU Chunwu; OUYANG Han; WANG Shuang; WANG Qian; SHI Zhuo

您当前的位置：

首页 >

文章列表页 >

Value of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) in prediction of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization

更新时间：2026-06-18

- Value of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) in prediction of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization
- Vol. 27, Issue 2, Pages: 82-87(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Online First：16 May 2018，
  
  Published：16 May 2018
- 稿件说明：
移动端阅览
朱正,赵心明,周纯武,等. 体素内不相干运动扩散加权成像在肝癌介入治疗预后中的价值[J]. 肿瘤影像学, 2018, 27(2): 82-87
DOI：

朱正,赵心明,周纯武,等. 体素内不相干运动扩散加权成像在肝癌介入治疗预后中的价值[J]. 肿瘤影像学, 2018, 27(2): 82-87 DOI：

摘要

目的：

探讨MR体素内不相干运动扩散加权成像（intravoxel incoherent motion diffusion weighted imaging，IVIM-DWI）指标预测肝细胞肝癌（hepatocellular carcinoma，HCC）经动脉化疗栓塞（transcatheter arterial chemoembolization，TACE）后无进展生存期（progression-free survival，PFS）的价值。

方法：

收集2014年9月30日2017年9月30日于北京协和医院肿瘤医院诊治的90例肝癌患者，在治疗前及治疗后4~6周内分别行IVIM-DWI检查。将性别、年龄、病变长径、瘤栓有无、AFP、ALT值6个临床指标，治疗前ADC、D、D*、f值，以及治疗后ADC、D、D*、f值8个MR功能学定量指标进行多因素分析。采用独立样本t检验、方差分析及

检验，以Kaplan-Meier生存曲线、Log-Rank检验、多因素Cox回归分析确定有预后价值的IVIM参数及临床指标。

结果：

性别、年龄、治疗前D*值、治疗前f值及治疗后D*值共5个指标在肝癌TACE治疗后的PFS中差异具有统计学意义（

性别

=0.030，

年龄

=0.005，

治疗前D*

0.001，

治疗前f值

=0.007，

治疗后D*

0.001）。即男性、高龄、高治疗前D*值、高治疗前f值及高治疗后D*值的患者预后差。以中位数为分界值，即年龄、治疗前D*值、治疗前f值和治疗后D*值4个指标分别以53岁、14.110

-3

/s、23.63%和11.910

-3

/s为界值，发现年龄及治疗前D*值2个指标预测预后的差异有统计学意义（

高龄组

=0.027，

治疗前D*

=0.003）。

结论：

年龄及治疗前D*值2个指标有助于预测肝癌TACE治疗的预后，即高龄、高治疗前D*值者预后更差。

Abstract

Objective:

To predict the value of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) in prediction of progression-free survival (PFS) of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE).

Methods:

Ninety patients were enrolled in this study from September 30

2014 to September 30

2017. A total of 14 parameters including 6 clinical indexes: gender

age

size of lesion

tumor thrombus

AFP and ALT values; and 8 functional MRI indexes: pretreatment ADC

posttreatment ADC

D* and f were analyzed by multivariate analysis. Independent sample t test

ANOVA

Kaplan-Meier survival curve

Log-Rank test and Cox regression analysis were used to determinate the prognostic value of IVIM parameters and clinical indicators.

Results:

Gender

age

pretreatment D*

f and posttreatment D* could predict the prognosis of HCC after TACE (

gender

=0.030

age

=0.005

pretreatment D*

0.001

pretreatment f

=0.007，

posttreatment D*

0.001). Using median (age=53 years

pretreatment D*=14.110

-3

pretreatment f=23.63%

posttreatment D*=11.910

-3

/s) as cut-off value

age and pretreatment D* showed statistical significance in predicting the prognosis of HCC (

age

=0.027

pretreatment D*

=0.003).

Conclusion:

Age and pretreatment D* value can predict the prognosis of HCC after TACE.

关键词

Keywords

references

Views

1552

下载量

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical application of CEUS in evaluation of the efficacy of local thermal ablation of hepatocellular carcinoma

Value of contrast-enhanced ultrasound in diagnosis of ≤10 mm hepatocellular carcinomas

Diagnostic value of combined ultrasound and photoacoustic imaging for sarcopenia

Predictive model for postoperative liver metastasis in pancreatic neuroendocrine tumors based on CT radiomics

Comparison of diagnostic yields and analysis of influencing factors of core needle biopsy guided by conventional ultrasound or contrast‑enhanced ultrasound for retroperitoneal tumors

Related Author

WANG Kun

DONG Yi

LIU Lingxiao

CHEN Rongxin

Bao Jingwen

CHEN Yanling

WANG Wenping

YUAN Kai

Related Institution

Department of Ultrasound, Zhongshan Hospital, Fudan University

Department of Interventional Radiology, Zhongshan Hospital, Fudan University

Department of Hepatic Oncology, Zhongshan Hospital, Fudan University

Shanghai Institute of Medical Imaing

Department of Ultrasound, Taicang First People&rsquo

AI问答

⁰